Welcome, you are shopping with

Tirzepatide

Starting at $449/mo

Price includes doctor consultation and shipping fees.
Final pricing will vary depending on your personalized prescription and tier.

(4.5 stars) • 131 reviews

Tirzepatide is designed to support weight management and improve metabolic health. It is a dual-action treatment that targets both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, offering a comprehensive approach to weight loss and glucose control.

  • Lose up to 26%+
  • No hidden membership, consultation, or shipping fees
  • Requires a 3 month commitment and weekly injections
  • A licensed doctor will determine your final dosing schedule after your consultation
  • Currently Not Available In: AL, AR, CA, HI, KS, MI, MN, MS, SC
    (We are working on expanding our coverage in the near future)
  • Although our partner pharmacies use only FDA-approved ingredients that are pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved.

Prescription appetite suppression:
Tirzepatide curbs appetite and reduces food cravings, promoting weight loss.

Scientifically backed weight loss aid: Tirzepatide is an effective weight loss aid, as demonstrated in clinical trials where some patients shed up to 22.5% of their body weight over 6-8 weeks.

Metabolic health booster:
Tirzepatide improves metabolic health by lowering blood sugar levels, improving insulin sensitivity, and decreasing the risk of health problems that often accompany obesity such as type 2 diabetes, high blood pressure, and cardiovascular disease.

Enhanced quality of life:
Tirzepatide assists in reaching a healthy weight, which can reduce symptoms like fatigue and joint pain linked to excess weight. It also improves mobility and boosts energy levels.

  • 90 day supply is billed monthly
  • Option to renew or cancel every 3 months
  • Doctor review within 48 hours
  • Processing can take 7 – 10 business days (subject to pharmacy partners)
  • Once ready, shipping is via 2-day

Pricing & Dosage

Tier 1

$449 / mo

Tier 2

$599 / mo

Tier 3

$799 / mo

  • You will be able to switch tier or GLP1 product every 3 months, after an assessment, based on your progress and goals.
  • Your dosing plan might vary based on the recommendations from a doctor on the Ellie MD platform.
  • Total units in vials vary by pharmacy; you will always receive enough for the given dosing schedule.
  • Patients not currently on a GLP1 medication will initiate their treatment on Tier 1. This is a standard procedure to ensure safety and effectiveness.

Testimonials

Read what our customers have to say about our products.

FAQs

Find answers to common questions about our weight loss products, including usage, ingredients, side effects and expected results.  

Tirzepatide is an FDA-approved weekly injection used to treat type 2 diabetes. Although its primary purpose is for diabetes management, doctors may prescribe it off-label for weight loss. Clinical trials have demonstrated that tirzepatide can aid in weight loss, despite lacking FDA approval specifically for this purpose.

At Ellie MD, our healthcare providers may prescribe a customized version of tirzepatide, potentially containing additional metabolic support ingredients. The pharmacy that ships your medication will depend on your state of residence, and each partnered pharmacy may offer its unique blend of metabolic support ingredients. As a result, you may receive different metabolic support ingredients based on your location.

Tirzepatide aids in weight loss by reducing hunger and increasing the feeling of fullness. It mimics the effects of natural hormones in your body, GLP-1 and GIP, which regulate appetite and blood sugar levels. Additionally, the medication slows down the emptying of your stomach, helping you feel satisfied sooner and remain full for an extended period.

Tirzepatide is generally safe when used as prescribed and monitored by a healthcare provider. However, like any medication, it can cause side effects. Common side effects of tirzepatide include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and resolve over time. In rare cases, more serious side effects like severe stomach or kidney problems may occur.

It’s important to discuss the potential risks and benefits of tirzepatide with your healthcare provider and to promptly report any side effects or concerns you may have.

Semaglutide is a medication approved by the FDA for treating type 2 diabetes and helping with long-term weight management. Tirzepatide is also FDA-approved for type 2 diabetes treatment. While it’s mainly used for diabetes, doctors may sometimes prescribe tirzepatide “off-label” to help with weight loss. Even though it hasn’t been officially approved for this purpose by the FDA, studies have shown that tirzepatide can help people lose weight.

Both semaglutide and tirzepatide are part of a group of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). They work by acting like a hormone called GLP-1, which helps control blood sugar levels. Tirzepatide goes a step further by also mimicking another hormone called glucose-dependent insulinotropic polypeptide (GIP). Research has found that the combined effect of GLP-1 and GIP in tirzepatide is more effective for weight loss compared to semaglutide.

The package will include a vial of the medication (sufficient for up to 12 weeks, subject to your location and chosen pharmacy), instructional materials (with web links to video content), insulin needles, and alcohol swabs.

Ellie MD’s weight loss medication must be refrigerated. Please refrigerate it promptly upon receiving the medication.

To be eligible for our weight loss medication, you must meet certain requirements:

1. You need to be at least 18 years old.
2. You must reside in one of the states where our services are available or be physically present there.
3. It’s important to demonstrate the necessity for medical treatment. If requested by your healthcare provider, our team can assist you in obtaining recent lab results.
4. You must meet the FDA-approved criteria for these medications. This means having a body mass index (BMI) above 30 for individuals with obesity, or a BMI above 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol.
5. You should not have certain medical conditions, including type 1 diabetes, a history of chronic pancreatitis or pancreatitis caused by weight loss medications (GLP-1), severe gastrointestinal (GI) disease, current gallbladder problems (except for previous gallbladder removal), retinal impairment/diabetic retinopathy, recent bariatric surgery, multiple endocrine neoplasia syndrome type 2 (MEN-2), or a history of medullary thyroid cancer.
6. You should not be pregnant or nursing.

Your healthcare provider affiliated with Ellie MD will make the final decision regarding your eligibility for the weight loss program and may request additional information directly from you.






Tirzepatide/Semaglutide may not be suitable for everyone.

The following conditions can prevent the use of semaglutide: personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, current use of another GLP-1 receptor agonist, diabetic ketoacidosis, known hypersensitivity to semaglutide or any of its injection components, recent bariatric surgery within the last 6 months, and pregnancy.

Additionally, it is important to inform your doctor if you have or have had a stomach or intestinal disorder, pancreatitis, kidney disease, or diabetes-induced eye problems.

Want to know more?

Contact us for more information.

Scientific Sources